Brean Murray Downgrades CardioNet (BEAT) to Hold; Lowers Estimates

November 9, 2009 9:25 AM EST

Brean Murray downgrades CardioNet (Nasdaq: BEAT) from Buy to Hold.

Brean analyst says, "While we are long-term believers in telemetry-based monitoring platforms, we are moving to the sidelines based on lack of visibility or positive catalysts for the stock in the near-term...We are reducing FY09 and FY10 estimates to $143 million and $128 million from $149 million and $133 million...Our GAAP EPS for FY09 and FY10 are reduced to ($0.44) and ($0.85), respectively."

To see more analyst ratings on BEAT Click Here.

CardioNet, Inc. provides ambulatory, continuous, real-time outpatient management solutions for monitoring relevant and timely clinical information regarding an individual's health in the United States.


Related Categories

Downgrades

Stocks Mentioned

BEAT 4.95

-0.08 -1.59%
Volume: 190,709
Track BEAT


Related Entities


Add Your Comment